Citadel Advisors’s Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 CANO.WS Stock Holding History

Citadel Advisors’s Portfolio CANO.WS Stock Details CANO.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-347,695	Closed	-$918K	–	15690
2022 Q3	$918K	Sell	347,695 -46,814	-12%	-$68.9K	﹤0.01%	7184
2022 Q2	$268K	Buy	394,509 +9	+0%	+$9	﹤0.01%	10067
2022 Q1	$623K	Sell	394,500 -375,773	-49%	-$541K	﹤0.01%	8861
2021 Q4	$1.84M	Sell	770,273 -53,551	-7%	-$162K	﹤0.01%	6441
2021 Q3	$3.4M	Buy	823,824 +416,105	+102%	+$1.57M	﹤0.01%	5090
2021 Q2	$1.5M	Buy	+407,719	New	+$1.84M	﹤0.01%	7313

Other funds holding CANO.WS

Zazove Associates Incline Village, Nevada $1.22B AUM 1.91% 1-Year Est. Return

ICM

Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

AWG

Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

JAIC

Josh Arnold Investment Consultant Edina, Minnesota $117M AUM 26.5% 1-Year Est. Return

Governors Lane New York $1.56B AUM 30.42% 1-Year Est. Return

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

Citadel Advisors's CANO.WS Position: Q4 2022 in Review

Citadel Advisors sold out of Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 (CANO.WS) in Q4 2022, closing a stake of 347,695 shares — an estimated $918K sold.

Citadel Advisors first reported a position in CANO.WS in Q2 2021 and held it in 6 quarters. The position peaked at $3.4M in Q3 2021. 27 funds tracked by Wall St. Rank hold CANO.WS as of Q4 2022.

Citadel Advisors reported no remaining Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 position as of Q4 2022 after selling out during the quarter.
Citadel Advisors sold 347,695 Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 shares in Q4 2022, an estimated $918K.
Citadel Advisors first reported a position in Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 in Q2 2021 and held it in 6 quarters.
Citadel Advisors's Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 position peaked at $3.4M in Q3 2021.
27 funds tracked by Wall St. Rank held Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 as of Q4 2022.

Based on Citadel Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.